| Treatment success | Loss to follow-up | ||||
---|---|---|---|---|---|---|
aRR‡ | 95% CI | p-valueÞ | aOR‡ | 95% CI | p-valueÞ | |
Residency | ||||||
 KT1¥ | 1.00 |  |  | 1.00 |  |  |
 KT2 | 0.95 | [0.88, 1.02] | 0.163 | 1.86 | [1.03, 3.36] | 0.041 |
 KT3 | 1.01 | [0.97, 1.05] | 0.685 | 0.59 | [0.30, 1.17] | 0.134 |
 KT4 | 0.95 | [0.92, 0.99] | 0.010 | 1.98 | [1.44, 2.72] | < 0.001 |
Sex | ||||||
 Male¥ | 1.00 |  |  | 1.00 |  |  |
 Female | 1.02 | [1.00, 1.05] | 0.078 | 0.80 | [0.60, 1.07] | 0.139 |
Age | ||||||
  < 25 years¥ | 1.00 |  |  | 1.00 |  |  |
 25–34 years | 1.00 | [0.97, 1.04] | 0.881 | 1.00 | [0.68, 1.46] | 0.982 |
 35–44 years | 1.01 | [0.97, 1.04] | 0.622 | 0.73 | [0.48, 1.11] | 0.142 |
 45–54 years | 1.00 | [0.96, 1.03] | 0.863 | 0.59 | [0.37, 0.93] | 0.024 |
  > 55 years | 0.93 | [0.89, 0.96] | < 0.001 | 0.58 | [0.36, 0.93] | 0.024 |
Patient type┼ | ||||||
 New¥ | 1.00 |  |  | 1.00 |  |  |
 Relapse | 0.89 | [0.84, 0.94] | < 0.001 | 1.09 | [0.69, 1.73] | 0.705 |
 Failure | 0.62 | [0.52, 0.75] | < 0.001 | 1.77 | [0.80, 3.95] | 0.160 |
 LTFU | 0.87 | [0.73, 1.02] | 0.085 | 1.79 | [0.69, 4.62] | 0.228 |
 Unknown | 0.97 | [0.92, 1.02] | 0.198 | 1.42 | [0.86, 2.36] | 0.171 |
 Transfer in | 0.88 | [0.81, 0.96] | 0.003 | 1.48 | [0.85, 2.60] | 0.170 |
Type of TB§,Π| ||||||
 AFB(+)¥ | 1.00 |  |  | 1.00 |  |  |
 AFB(−) | 1.06 | [1.03, 1.09] | < 0.001 | 0.79 | [0.55, 1.12] | 0.184 |
 EP | 1.05 | [1.02, 1.08] | 0.001 | 0.77 | [0.55, 1.08] | 0.126 |
HIV/AIDS¶ | ||||||
 No/Unknown¥ | 1.00 |  |  | 1.00 |  |  |
 Yes | 0.77 | [0.73, 0.82] | < 0.001 | 2.18 | [1.55, 3.06] | < 0.001 |
Diabetes | ||||||
 No/Unknown¥ | 1.00 |  |  | 1.00 |  |  |
 Yes | 0.96 | [0.91, 1.02] | 0.159 | 1.15 | [0.65, 2.03] | 0.619 |